CEL-SCI (FRA:LSR) Tariff Resilience Score: 5/10 (As of Jun. 29, 2026)


FRA:LSR CEL-SCI Corp FRA:LSR
30 GF Score
Price €0.76
! 2 Warning Signs
View Full Analysis

What is CEL-SCI Tariff Resilience Score?

CEL-SCI FRA:LSR -9.52% 30 Tariff Resilience Score is 5 as of Jun. 29, 2026. GuruFocus rates FRA:LSR with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,376 Biotechnology companies, CEL-SCI ranks better than 62.21% on this metric.

CEL-SCI has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

CEL-SCI has CEL-SCI Corp is moderately vulnerable due to its reliance on international clinical trials and imported materials. The company can mitigate risks through strategic partnerships and local manufacturing agreements.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes CEL-SCI might have Average Resilient.

CEL-SCI  (FRA:LSR) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

CEL-SCI Tariff Resilience Score Related Terms

FRA:LSR vs OTLC, AEON, CLRB: Tariff Resilience Score Comparison

For the Biotechnology subindustry, CEL-SCI's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CEL-SCI Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CEL-SCI's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where CEL-SCI's Tariff Resilience Score falls into.


FRA:LSR
30GF Score
CEL-SCI Corp FRA:LSR
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
CEL-SCI (FRA:LSR) has a Tariff Resilience Score of 5 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, CEL-SCI ranks #520 out of 1376 companies in the Biotechnology industry, placing it in the top 37.8%.
Is CEL-SCI's Tariff Resilience Score too high?
CEL-SCI's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. CEL-SCI's value of 5 is 25% above this industry median. Based on the distribution chart, CEL-SCI ranks #520 out of 1376 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CEL-SCI has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does CEL-SCI's Tariff Resilience Score compare to OTLC and AEON?
According to the Biotechnology industry distribution chart, CEL-SCI ranks #520 out of 1376 companies for Tariff Resilience Score. This puts CEL-SCI in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. CEL-SCI's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,376 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CEL-SCI's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CEL-SCI's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEL-SCI stock overvalued right now?
CEL-SCI (FRA:LSR) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. CEL-SCI's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For CEL-SCI (FRA:LSR), the current Tariff Resilience Score is 5 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEL-SCI Business Description

Other Exchanges CVM:USA
Address 8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
30GF Score

Get the complete analysis for FRA:LSR

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price